Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

5.63
Delayed Data
As of Jul 29
 +0.18 / +3.30%
Today’s Change
2.85
Today|||52-Week Range
8.48
+4.26%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close5.45
Today’s open5.42
Day’s range5.42 - 5.68
Volume317,424
Average volume (3 months)439,049
Market cap$169.9M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-17.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...-0.28-3.37%
LNTHLantheus Holdings In...0.000.00%
VCYTVeracyte Inc-0.01-0.20%
QTNTQuotient Ltd-1.70-22.67%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs